Cronos Group Reports Amended Deal With Ginkgo Bioworks To Accelerate Commercialization Of Cultered Cannabinoids; Cronos Begins Commercial Production Of Cannabigerol
Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) (“Cronos Group”), an innovative global cannabinoid company, and Ginkgo Bioworks, Inc. (“Ginkgo”), which is building the leading horizontal platform for
24 Stocks Moving in Friday’s Pre-Market Session
Gainers
Senseonics Holdings, Inc. (NYSE: SENS) rose 37.1% to $2.81 in pre-market trading after the company disclosed results from a PROMISE study evaluating its Eversense CGM System for up to 180 days. The Eversense CGM is a continuous glucose monitoring device.
Campaign Launches to Try to Force Palantir Out of Britain’s NHS
-CNBC
https://www.cnbc.com/2021/06/04/campaign-launched-to-get-palantir-out-of-nhs.html?utm_term=Autofeed&utm_medium=Social&utm_content=Main&utm_source=Twitter#Echobox=1622800070
55 Biggest Movers From Yesterday
Gainers
DLocal Limited (NASDAQ: DLO) shares jumped 54.2% to close at $32.39 on Thursday. DLocal raised around $92.6 million from the sale of 4.4 million shares in its IPO.